• Clinical evidence

    *Stage 1 hypertension

    Dose-dependent systolic blood pressure (SBP) reductions with valsartan-based therapies*

    *In regression analysis, the slope of change from baseline in...

  • Secondary Progressive Multiple Sclerosis

    Progressive types of MS:

    Progressive MS can come after RRMS, where it is called Secondary Progressive (SPMS), or it can start as progressive from the very onset, where it is called Primary Progressive (PPMS)....

  • Confidence

    GILENYA reduced the risk of relapse vs teriflunomide 2

    Adapted from Kalincik et al, 2019.2 A propensity score -matched analysis of the global observational MSBase cohort comparing...

  • About MS

    MS Overview

    Multiple sclerosis (MS) is a chronic, inflammatory neurodegenerative autoimmune disease of the central nervous system (CNS) leading to demyelinating plaques or lesions in the brain or spinal cord. 1-3...

  • About Migraine

    Migraine Overview

    Migraine is a distinct neurological disease that:

    Is typically characterized by recurrent unilateral headache of moderate to severe pain intensity that can be described as throbbing in quality 1 Can be...

  • PsA epidemiology and pathophysiology

    Disease overview

    PSA is a chronic, progressive, inflammatory disorder of joints and skin 1,2 It is associated with 6 main features: Arthritis, Enthesitis, Dactilitis, Nail psoriasis , Psoriasis, Axial involvement....

  • About Hypertension

    Global impact of an elevated hypertension (1/2)

    In 2015, elevated systolic BP was the leading preventable cause of premature death globally ~10 million deaths are reported due to elevated blood pressure >...

  • Product information

    Dosage and administration:

    Antidiabetic treatment should be individualized on the basis of effectiveness and tolerability. When using Galvumet, the maximum recommended daily dose of 100 mg vildagliptin should not be exceeded...

  • Relapsing Remitting Multiple Sclerosis

    The majority of patients with MS have a relapsing - remitting onset followed by a clinical continuum to progression 1-3

    MS Relapses and Disability

    An MS relapse or exacerbation causes new neurological...

  • Basic Succinct Statement

    Beovu® (brolucizumab)

    120 mg/mL solution for injection in pre-filled syringe

    Beovu®

    ▼This medicinal product is subject to additional monitoring. This allows quick...

page 

Pages

 of  3
×

Ask Speakers

×

Medical Information Request